Factors associated with fatigue in patients with systemic lupus erythematosus in an outpatient tertiary care setting: a cross-sectional cohort study

OBJECTIVES: Fatigue is one of the most common and debilitating symptoms experienced by patients with systemic lupus erythematosus (SLE). Previous studies revealed the association of fatigue with various SLE and non-SLE-related factors. This study aims to explore the prevalence of fatigue and the factors that are associated with fatigue experienced by SLE patients in an outpatient rheumatology clinic setting. DESIGN: Prospective, observational study using a sample of convenience. SETTING: Outpatient rheumatology clinic at a tertiary care centre. PARTICIPANTS: Consecutive subjects with SLE presenting for their outpatient visits enrolled in the ongoing Institutional Review Board-approved 'Pathogenesis and Natural History of SLE' protocol. PRIMARY AND SECONDARY OUTCOME MEASURES: Disease activity and organ damage accrual were measured by Safety of Estrogens in Lupus Erythematosus: National Assessment Version of the Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI) and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI), respectively. Fatigue was measured by the self-reported Fatigue Severity Scale (FSS), and a score of ≥4 was used to define clinically significant fatigue. Correlation analyses were done to determine the association between fatigue and patient demographics, and SLE disease activity and damage indices. Results were considered as statistically significant at p<0.05. All data analyses were carried out with the SAS program, release V.9.4 (SAS Institute). RESULTS: (p=0.03). CONCLUSIONS: Our study found that organ damage accrual, specifically pulmonary fibrosis and neuropathy as measured by SLICC-ACR DI and high BMI, is associated with clinically significant fatigue in SLE. Furthermore, our results support previous findings that fatigue is independent of SLE disease activity. Findings of our study need to be replicated in independent SLE cohorts measuring fatigue at multiple time points. Mechanistic studies are needed to better understand pathogenesis of fatigue in SLE.

Authors

Institutions

Publication Details

Journal
BMJ Open
Published
2026-04-01
DOI
https://doi.org/10.1136/bmjopen-2025-104786
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Factors associated with fatigue in patients with systemic lupus erythematosus in an outpatient tertiary care setting: a cross-sectional cohort study

Sarfaraz Hasni, Zerai Manna, Ann Biehl, Miraa Qutab et al.
BMJ Open
Systemic Lupus Erythematosus Research
article

Factors associated with fatigue in patients with systemic lupus erythematosus in an outpatient tertiary care setting: a cross-sectional cohort study

Sarfaraz Hasni, Zerai Manna, Ann Biehl, Miraa Qutab, Ali M. Rizvi, Adam D. Munday, Marquis Chapman
article en

Abstract

OBJECTIVES: Fatigue is one of the most common and debilitating symptoms experienced by patients with systemic lupus erythematosus (SLE). Previous studies revealed the association of fatigue with various SLE and non-SLE-related factors. This study aims to explore the prevalence of fatigue and the factors that are associated with fatigue experienced by SLE patients in an outpatient rheumatology clinic setting. DESIGN: Prospective, observational study using a sample of convenience. SETTING: Outpatient rheumatology clinic at a tertiary care centre. PARTICIPANTS: Consecutive subjects with SLE presenting for their outpatient visits enrolled in the ongoing Institutional Review Board-approved 'Pathogenesis and Natural History of SLE' protocol. PRIMARY AND SECONDARY OUTCOME MEASURES: Disease activity and organ damage accrual were measured by Safety of Estrogens in Lupus Erythematosus: National Assessment Version of the Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI) and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SLICC/ACR DI), respectively. Fatigue was measured by the self-reported Fatigue Severity Scale (FSS), and a score of ≥4 was used to define clinically significant fatigue. Correlation analyses were done to determine the association between fatigue and patient demographics, and SLE disease activity and damage indices. Results were considered as statistically significant at p<0.05. All data analyses were carried out with the SAS program, release V.9.4 (SAS Institute). RESULTS: (p=0.03). CONCLUSIONS: Our study found that organ damage accrual, specifically pulmonary fibrosis and neuropathy as measured by SLICC-ACR DI and high BMI, is associated with clinically significant fatigue in SLE. Furthermore, our results support previous findings that fatigue is independent of SLE disease activity. Findings of our study need to be replicated in independent SLE cohorts measuring fatigue at multiple time points. Mechanistic studies are needed to better understand pathogenesis of fatigue in SLE.

BMJ OpenVol. 16(4)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (US), Post Graduate Medical Institute (PK), National Institutes of Health Clinical Center (US)
U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Openalex Percentile: Top 35%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.